Fruquintinib with programmed cell death ‐ 1 inhibitors versus triflueridine ‐ tipiracil ‐ 102 with bevacizumab in late‐line mCRC : A retrospective cohort study based on propensity score matching

Documenti analoghi

• Association of early versus late tracheostomy with prognosis in hypoxic‐ischaemic encephalopathy patients: A propensity‐matched cohort study
  di: Yeling Li, et al.
  Pubblicazione: (2025)
• Effects of epidural analgesia at 1 cm cervical dilatation on multiparae: A retrospective cohort study using propensity score‐matching
  di: Shunbin Chen, et al.
  Pubblicazione: (2024)
• Belimumab in early systemic lupus erythematosus: A propensity score matching analysis
  di: Chaofan Lu, et al.
  Pubblicazione: (2024)
• Efficacy and safety of RS plus bevacizumab versus RS plus fruquintinib as the third‐line therapy in patients with refractory metastatic colorectal cancer: A real‐world propensity score matching study
  di: Yuwen Zhou, et al.
  Pubblicazione: (2024)
• Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching
  di: Kaiqi Lan, et al.
  Pubblicazione: (2025)